Fig. 1From: Oral versus intravenous clarithromycin in moderate to severe community-acquired pneumonia: an observational studyKaplan-Meier plot of 30-day mortality between patients receiving oral or intravenous clarithromycin for moderate to severe community-acquired pneumoniaBack to article page